Literature DB >> 17425696

Solitary extramedullary plasmacytoma of the canine larynx.

A M Hayes1, S P Gregory, S Murphy, J F McConnell, J C Patterson-Kane.   

Abstract

An 11-year-old, female, spayed cocker spaniel was presented with dysphonia caused by a solitary laryngeal mass. Excisional biopsy was performed, and a diagnosis of plasmacytoma was made on the basis of histological examination. Further investigations showed no signs of systemic involvement. Coarse fractionated radiation therapy failed to control the tumour. Therapy was successfully instituted with a conventional combination chemotherapy protocol over a period of 14 months. The dog remains disease free 30 months after diagnosis. Most solitary, extramedullary plasmacytomas in dogs arise in the gastrointestinal tract, with fewer reports in other sites. The larynx is an uncommon sight of involvement in any species, and to the authors' knowledge, this is the first report of this tumour type in the canine larynx. In contrast to the therapeutic benefits reported in humans, the combination of surgery and radiation therapy was unsuccessful in this case, although sustained remission was gained following chemotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17425696     DOI: 10.1111/j.1748-5827.2006.00265.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  3 in total

1.  Surgery and radiation therapy for extramedullary plasmacytoma of the penile mucosa in a dog.

Authors:  Jackie M Wypij; Louis-Philippe de Lorimier
Journal:  Can Vet J       Date:  2012-09       Impact factor: 1.008

2.  Tonsillar plasmacytoma in a dog.

Authors:  Yoshimi Iwaki; Colleen Monahan; Rebecca Smedley; David Upchurch; Paulo Vilar-Saavedra
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

3.  Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid.

Authors:  S E Sykes; V Byfield; L Sullivan; S J Bender; P F Moore; M D Sánchez
Journal:  J Comp Pathol       Date:  2016-12-22       Impact factor: 1.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.